Macrogen, Inc. (KOSDAQ:038290)

Market Cap	165.98B
Revenue (ttm)	163.92B
Net Income (ttm)	-6.47B
Shares Out	10.84M
EPS (ttm)	-620.90
PE Ratio	n/a
Forward PE	32.51
Dividend	300.00 (1.94%)
Ex-Dividend Date	Dec 27, 2024

Volume	18,682
Average Volume	17,617
Open	15,500
Previous Close	15,490
Day's Range	15,250 - 15,540
52-Week Range	14,700 - 19,150
Beta	0.69
RSI	39.99
Earnings Date	Aug 14, 2025

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S...

• Industry: Commercial Physical and Biological Research
• Founded: 1997
• Employees: 500
• Stock Exchange: KOSDAQ
• Ticker Symbol: 038290

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.